Because circulating levels of FABP4 are associated with obesity and metabolic diseases, we investigated the relationship between HFD, PrSC activation and PCa progression in an in vivo model. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.